These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The molecular genetics of pancreatic ductal carcinoma. Sohn TA. Minerva Chir; 2002 Oct; 57(5):561-74. PubMed ID: 12370658 [Abstract] [Full Text] [Related]
3. Preinvasive pancreatic neoplasia of ductal phenotype induced by acinar cell targeting of mutant Kras in transgenic mice. Grippo PJ, Nowlin PS, Demeure MJ, Longnecker DS, Sandgren EP. Cancer Res; 2003 May 01; 63(9):2016-9. PubMed ID: 12727811 [Abstract] [Full Text] [Related]
4. Inactivation of Smad4 accelerates Kras(G12D)-mediated pancreatic neoplasia. Kojima K, Vickers SM, Adsay NV, Jhala NC, Kim HG, Schoeb TR, Grizzle WE, Klug CA. Cancer Res; 2007 Sep 01; 67(17):8121-30. PubMed ID: 17804724 [Abstract] [Full Text] [Related]
5. Epigenetic changes of pituitary tumor-derived transforming gene 1 in pancreatic cancer. Zhang ML, Lu S, Zheng SS. Hepatobiliary Pancreat Dis Int; 2008 Jun 01; 7(3):313-7. PubMed ID: 18522889 [Abstract] [Full Text] [Related]
6. Preinvasive duct-derived neoplasms in pancreas of keratin 5-promoter cyclooxygenase-2 transgenic mice. Müller-Decker K, Fürstenberger G, Annan N, Kucher D, Pohl-Arnold A, Steinbauer B, Esposito I, Chiblak S, Friess H, Schirmacher P, Berger I. Gastroenterology; 2006 Jun 01; 130(7):2165-78. PubMed ID: 16762637 [Abstract] [Full Text] [Related]
7. Ductal origin of pancreatic adenocarcinomas induced by conditional activation of a human Ha-ras oncogene in rat pancreas. Ueda S, Fukamachi K, Matsuoka Y, Takasuka N, Takeshita F, Naito A, Iigo M, Alexander DB, Moore MA, Saito I, Ochiya T, Tsuda H. Carcinogenesis; 2006 Dec 01; 27(12):2497-510. PubMed ID: 16774944 [Abstract] [Full Text] [Related]
13. Pancreatic cancer development and progression: remodeling the model. Real FX, Cibrián-Uhalte E, Martinelli P. Gastroenterology; 2008 Sep 01; 135(3):724-8. PubMed ID: 18692502 [No Abstract] [Full Text] [Related]
15. Dynamics of the immune reaction to pancreatic cancer from inception to invasion. Clark CE, Hingorani SR, Mick R, Combs C, Tuveson DA, Vonderheide RH. Cancer Res; 2007 Oct 01; 67(19):9518-27. PubMed ID: 17909062 [Abstract] [Full Text] [Related]
16. Pancreatic cancer: translating lessons from mouse models and hereditary syndromes. Wescott MP, Rustgi AK. Cancer Prev Res (Phila); 2008 Dec 01; 1(7):503-6. PubMed ID: 19138999 [Abstract] [Full Text] [Related]
17. Ductal pancreatic cancer in humans and mice. Tuveson DA, Hingorani SR. Cold Spring Harb Symp Quant Biol; 2005 Dec 01; 70():65-72. PubMed ID: 16869739 [Abstract] [Full Text] [Related]
18. Molecular pathogenesis of pancreatic cancer. Maitra A, Kern SE, Hruban RH. Best Pract Res Clin Gastroenterol; 2006 Apr 01; 20(2):211-26. PubMed ID: 16549325 [Abstract] [Full Text] [Related]
19. Pancreatic cancer: a plea for good and comprehensive morphological studies. Algül H, Schmid RM. Eur J Gastroenterol Hepatol; 2008 Aug 01; 20(8):713-5. PubMed ID: 18617774 [Abstract] [Full Text] [Related]